HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $9 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Alpha Tau Medical (NASDAQ:DRTS) and maintained a price target of $9.
May 16, 2024 | 5:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Alpha Tau Medical and maintained a price target of $9.
The reiteration of a Buy rating and the maintenance of a $9 price target by HC Wainwright & Co. is a positive signal for investors, likely boosting short-term confidence and potentially driving the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100